Question Bank › Proven engine, fuel already in the tank

Proven engine, fuel already in the tank

Proven engine, fuel already in the tank: a working growth driver plus already-held means to multiply it

Calls Tested
496
Answered YES
100
Hit Rate
20.2%
rare by design

Fresenius Medical Care AG & Co. KGaA (FMS) — this company's answers

NO on the Q2 2018 call 2018-07-31 C
The model's full reasoning — Q2 2018 call → NO我们根据提供的电话会议记录来判断。问题要求确认管理层是否同时描述了同一业务的两个方面:(1) 一个已经产生实际业务的增长引擎,且其渗透率仍较小;(2) 公司已经拥有扩大该引擎的手段。我们需要在管理层自己的话中找到这两点。 浏览记录:管理层讨论了多个业务领域。我们寻找一个具体的增长引擎,它已经在产生实际收入,但仍有很大空间,并且公司已有资源扩大它。 一个可能的候选是“Care Coordination”业务。他们在讨论其利润率改善和收入下降,但提到“Care Coordination margin improvement and revenue decline came in as expected”,以及后来提到“Care Coordination in Asia Pacific is doing about 20% of that is acquisition, the other 12 is organic”,但这不是重点。另一个是“dialysis products”增长,但那是产品业务。 更具体地,管理层提到了“Calcimimetics”,但那是药物,不是增长引擎。 再想想:有“ESCOs”(负责的护理组织)吗?他们说“we're roughly at about 41,000 patients in the ESCOs”,但那是相对成熟的。 有没有提到一个新的增长引擎?可能是“PD products”或“China”市场。在回答Tom Jones的问题时,Rice Powell谈到了在中国投资生产PD能力,说“we're putting production capability in for PD”,以及“we've also put more people on the ground in China”。这可能是正在进行的增长,但“PD”在中国是已有业务吗?他们提到“we have been servicing the PD market in Asia Pacific out of EMEA”,现在要本地化生产。但这是否是一个已经产生实际收入的引擎?是的,PD业务已经在运行。但渗透率是否小?他们提到“we're putting production capability in for PD”是投资,但没说它有多小。 另一个可能是“Vifor”合资企业?但那是新的。 更明确的是,在回答关于欧洲利润压力的提问时,提到投资于“Vifor - Fresenius Medical Care joint venture”的Veltassa开发,但那是新药推广。 或许更合适的是“next stage”交易?但那是收购,不是增长引擎。 我们看管理层是否明确描述了一个“已经产生实际业务但仍在早期”的引擎。在回答Lisa Clive关于捆绑支付问题后,Rice Powell提到“we're fairly active talking about rates”但那是防御性的。 或许在回答Patrick Wood关于加州问题时,提到“we've budgeted money to defend ourselves”那是防御。 我们需要一个正面的增长故事。 在回答Tom Jones关于亚洲太平洋的问题时,Rice Powell讨论了中国投资,但没有明确说“已经产生的业务”和“渗透率小”同时出现。 也许“dialysis products”业务?管理层说“North America at 10% is doing quite well”,但那是成熟业务。 另一个候选是“Care Coordination”的“pharmacy services”?但收入在下降。 让我们逐段看:管理层在幻灯片中强调了“solid organic growth”等。 或许在回答Varonika关于欧洲投资时,提到了“Vifor”合资企业,但那是计划中的。 或许“sorbent dialysis”技术?但那是未来计划。 再看一遍记录中管理层关于增长引擎的明确描述:在开头,Rice Powell说“we're on track to achieve our 2018 targets”,然后提到“3% growth for clinics, patients and treatments”,这是核心业务,但那是成熟业务。 在解答Tom Jones的第二个问题时,Rice Powell谈到了“the PD space”,提到了“Liberty cycle”和“Salencia cycler”,以及“JV with Debiotech”和“sorbent”技术,但这些都是产品,不是已经产生大量实际收入的。 或许更关键的是,管理层提到了“Care Coordination”的改善,但那是从亏损中改善。 或许“US dialysis business”有“Calcimimetics”的影响,但那不是增长引擎。 让我们再读一下问题:它要求“a proven, already-producing growth engine that is still small relative to its room”和“the means to multiply it are already in the company's hands”。有没有一处管理层明确说“这个业务已经产生收入,但我们只触及了表面,而且我们已经有资源扩大它”? 在谈话中,Rice Powell在幻灯片6提到“Care Coordination margin improvement and revenue decline came in as expected.

← Back to the full FMS analysis

Show the exact prompt the model was given
Using ONLY the supplied earnings call transcript and no outside information: On this call, does management describe BOTH of the following about the SAME part of the business, as one connected present-tense story? (1) A PROVEN, ALREADY-PRODUCING GROWTH ENGINE THAT IS STILL SMALL RELATIVE TO ITS ROOM. Management identifies a specific driver of growth — a product, service, offering, location type, customer relationship, market, asset, or capability, in whatever form fits the industry — that is ALREADY generating real business today (actual revenue, orders, customers, volumes, output, or usage in the recent period, described with concrete substance rather than as pipeline, plans, or market opportunity), and management conveys, directly or plainly in substance, that this driver has so far captured only a small part of what it can reach — because it is early in its rollout, present in only a fraction of the customers, sites, applications, or territory available to it, or recently started and still ramping — so that the reported results reflect only the beginning of what this engine is already doing. (2) THE MEANS TO MULTIPLY IT ARE ALREADY IN THE COMPANY'S HANDS. Management describes resources the company ALREADY possesses or has ALREADY secured that it is now using, or beginning to use, to scale that same driver up — in whatever form fits the business: cash or self-generated funds being deployed into it; capacity, facilities, inventory, or supply already built or secured that it can fill; an existing customer base, footprint, network, or channel through which it can be pushed; approvals, qualifications, or positions already held that permit its expansion; a repeatable formula, site type, or playbook already demonstrated that is now being replicated; or people and capability already in place being pointed at it. The multiplication must be presented as already underway or already resourced from what the company has — not dependent on raising outside money, winning approvals not yet obtained, or demand that has not yet appeared. Answer YES when both halves are present in management's own words and connected — the engine is real and producing now, its captured share of its own opportunity is still small, and the company is already applying means it already holds to make it bigger — so that the just-reported numbers describe a company visibly smaller than the one management is already building with its own resources. Answer NO if the growth driver is only a plan, pilot without real paying activity, launch with nothing yet sold, or market opportunity. NO if the driver is already mature, already the dominant established business running at its full reach, or already fully reflected in results with no meaningful room described. NO if scaling it depends chiefly on outside financing not yet raised, approvals not yet granted, partners not yet signed, or demand not yet visible. NO if the 'room ahead' is expressed only as a generic total-addressable-market statistic or big-market talk without management conveying how little of the accessible opportunity this driver has captured. NO if the expansion resources are only planned, budgeted for later, or contingent. NO if the company is chiefly defending weak results, cutting back, or promising a turnaround. NO if either half appears only in an analyst's question or model that management does not itself affirm. Use only the supplied transcript. Answer only YES or NO.

Companies that answered YES

TickerCompanyCallDateCall grade
ASO Academy Sports and Outdoors, Inc. Q1 2024 2024-06-11 C+
NOAH Noah Holdings Limited Q1 2024 2024-05-30 D
WRBY Warby Parker Inc. Q1 2024 2024-05-09 A
LINC Lincoln Educational Services Corporation Q1 2024 2024-05-06 B+
ROCK Gibraltar Industries, Inc. Q1 2024 2024-05-01 B+
LTRX Lantronix, Inc. Q3 2024 2024-04-29 C
TNET TriNet Group, Inc. Q1 2024 2024-04-26 C
APYX Apyx Medical Corporation Q4 2023 2024-03-21 C
HUYA HUYA Inc. Q4 2023 2024-03-19 C
GIII G-III Apparel Group, Ltd. Q4 2024 2024-03-14 C
NICE NICE Ltd. Q4 2023 2024-02-22 B+
OUT Outfront Media Inc. Q4 2023 2024-02-21 C+
PUMP ProPetro Holding Corp. Q4 2023 2024-02-21 C+
DXCM DexCom, Inc. Q4 2023 2024-02-08 B+
SCPH scPharmaceuticals Inc. Q3 2023 2023-11-08 B
OPAD Offerpad Solutions Inc. Q3 2023 2023-11-01 C
APAM Artisan Partners Asset Management Inc. Q3 2023 2023-11-01 C+
RVLV Revolve Group, Inc. Q3 2023 2023-11-01 C
DASH DoorDash, Inc. Q3 2023 2023-11-01 C+
FSBC Five Star Bancorp Q3 2023 2023-10-31 B
TGLS Tecnoglass Inc. Q2 2023 2023-08-08 A
PTLO Portillo's Inc. Q2 2023 2023-08-05 B
SPT Sprout Social, Inc. Q2 2023 2023-08-04 B+
AFL Aflac Incorporated Q2 2023 2023-08-02 C+
NMR Nomura Holdings, Inc. Q1 2024 2023-08-02 D
BRX Brixmor Property Group Inc. Q1 2023 2023-05-02 A
DKS DICK'S Sporting Goods, Inc. Q4 2022 2023-03-07 B
M Macy's, Inc. Q4 2022 2023-03-02 D
TGT Target Corporation Q4 2022 2023-02-28 C
TOST Toast, Inc. Q4 2022 2023-02-16 C+
ADPT Adaptive Biotechnologies Corporation Q4 2022 2023-02-14 C+
HBAN Huntington Bancshares Incorporated Q4 2022 2023-01-20 B
WGO Winnebago Industries, Inc. Q1 2023 2022-12-16 D
SOL ReneSola Ltd Q3 2022 2022-12-01 C+
BLZE Backblaze, Inc. Q3 2022 2022-11-11 D
SIBN SI-BONE, Inc. Q3 2022 2022-11-07 C+
SYY Sysco Corporation Q1 2023 2022-11-01 C+
KEY KeyCorp Q3 2022 2022-10-20 B+
TMCI Treace Medical Concepts, Inc. Q2 2022 2022-08-13 B+
HLNE Hamilton Lane Incorporated Q1 2023 2022-08-02 C+
SYM Symbotic Inc. Q3 2022 2022-08-01 B+
UPWK Upwork Inc. Q2 2022 2022-07-27 C+
OGI OrganiGram Holdings Inc. Q3 2022 2022-07-14 B+
KFY Korn Ferry Q4 2022 2022-06-22 B
SE Sea Limited Q1 2022 2022-05-17 F
FLYW Flywire Corporation Q1 2022 2022-05-14 B+
ZVIA Zevia PBC Q1 2022 2022-05-12 B
IRTC iRhythm Technologies, Inc. Q1 2022 2022-05-07 C+
BXP Boston Properties, Inc. Q1 2022 2022-05-03 A
FAT FAT Brands Inc. Q4 2021 2022-03-21 F
RELY Remitly Global, Inc. Q4 2021 2022-03-02 B
FLUX Flux Power Holdings, Inc. Q2 2022 2022-02-10 D
VVV Valvoline Inc. Q1 2022 2022-02-09 C+
GTES Gates Industrial Corporation plc Q4 2021 2022-02-07 C+
SLQT SelectQuote, Inc. Q2 2022 2022-02-07 F
GFS GLOBALFOUNDRIES Inc. Q3 2021 2021-11-30 A
LOW Lowe's Companies, Inc. Q3 2021 2021-11-17 B+
KTB Kontoor Brands, Inc. Q3 2021 2021-11-04 A
LPTH LightPath Technologies, Inc. Q4 2021 2021-09-09 D
ASAN Asana, Inc. Q2 2022 2021-09-01 B+
CPRX Catalyst Pharmaceuticals, Inc. Q2 2021 2021-08-10 C+
OWL Blue Owl Capital Inc. Q2 2021 2021-08-10 B+
LOPE Grand Canyon Education, Inc. Q2 2021 2021-08-08 C
EEX Emerald Holding, Inc. Q2 2021 2021-08-01 C+
ESRT Empire State Realty Trust, Inc. Q2 2021 2021-07-29 C+
TENB Tenable Holdings, Inc. Q2 2021 2021-07-27 A
JPM JPMorgan Chase & Co. Q2 2021 2021-07-13 A
CMTL Comtech Telecommunications Corp. Q1 2019 2018-12-07 B+
ADSK Autodesk, Inc. Q3 2019 2018-11-20 A
ALB Albemarle Corporation Q3 2018 2018-11-08 B
UMH UMH Properties, Inc. Q3 2018 2018-11-02 C+
AGIO Agios Pharmaceuticals, Inc. Q3 2018 2018-11-01 C
AMGN Amgen Inc. Q3 2018 2018-10-30 B+
CUBI Customers Bancorp, Inc. Q3 2018 2018-10-26 C+
T AT&T Inc. Q3 2018 2018-10-24 C+
STM STMicroelectronics NV Q3 2018 2018-10-24 C+
LRN Stride, Inc. Q1 2019 2018-10-23 B
IRT Independence Realty Trust, Inc. Q2 2018 2018-08-02 B
XOM Exxon Mobil Corporation Q2 2018 2018-07-27 C
MKC McCormick & Company, Incorporated Q2 2018 2018-06-28 C+
LAUR Laureate Education, Inc. Q1 2018 2018-05-13 B+
NOVT Novanta Inc. Q4 2017 2018-05-12 B+
ILMN Illumina, Inc. Q1 2018 2018-04-24 A
ATI Allegheny Technologies Incorporated Q1 2018 2018-04-24 B
TOUR Tuniu Corporation Q4 2017 2018-03-14 D
UPLD Upland Software, Inc. Q4 2017 2018-03-08 C+
FI Fiserv, Inc. Q4 2017 2018-02-27 C
UNH UnitedHealth Group Incorporated Q4 2017 2018-01-16 A
MITK Mitek Systems, Inc. Q4 2017 2017-11-07 C+
UAA Under Armour, Inc. Q3 2017 2017-10-31 F
IR Ingersoll-Rand Plc Q3 2017 2017-10-25 B
MKTX MarketAxess Holdings Inc. Q3 2017 2017-10-25 C+
GNTX Gentex Corporation Q3 2017 2017-10-20 B
BCE BCE Inc. Q2 2017 2017-08-05 B+
CCOI Cogent Communications Holdings, Inc. Q2 2017 2017-08-03 B
IONS Ionis Pharmaceuticals, Inc. Q1 2017 2017-05-09 C
LBTYK Liberty Global's Q1 2016 2016-05-10 C+
GOGO Gogo Inc. Q1 2016 2016-05-06 C+
DD DuPont de Nemours, Inc. Q1 2016 2016-04-26 B+
WK Workiva Inc. Q4 2015 2016-03-01 B

How the model reasoned

NMR · Q1 2024 → YESThe question is whether management describes BOTH a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...YES The transcript shows management describing the Retail business as a growth engine that's already producing real results (net revenue up 22%, income up 133% after reorganization in March, recurring and flow revenue benefits starting to appear) but still small relative to its room (only 1,600 partners deployed out of a much larger potential base, with Q-on-Q progress negative from uncontacted clients, and explicit statements like "if we can broaden our partner base, then we will start to see the benefit" and "we have not been able to contact all clients").
OWL · Q2 2021 → YESThe question is whether management describes BOTH a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...YES The transcript shows management describing Direct Lending as a proven growth engine already producing real activity ($5.1 billion gross deployments in the quarter, $31 billion AUM) while still small relative to its opportunity (explicitly "very small relative to total market opportunity" with a $300 billion market and $1. 5 trillion PE dry powder). They connect this directly to the means already in hand: existing sponsor relationships (500), $8.
WRBY · Q1 2024 → YESThe question is: Does management describe BOTH of a proven, already-producing growth engine that's still small relative to its room, AND the means to multiply it already in the company's hands, as one...

More from the question bank

Sizing the constraint out loudFixed price, unfixed volumeThe lull that never cameFront, middle, and back of the business all Doing it our way nowThe hard part is already doneAll questions →
Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.